Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

QbD approach to HPLC method development and validation of ceftriaxone sodium

View through CrossRef
Abstract Background Quality by design (QbD) refers to the achievement of certain predictable quality with desired and predetermined specifications. A quality-by-design approach to method development can potentially lead to a more robust/rugged method due to emphasis on risk assessment and management than traditional or conventional approach. An important component of the QbD is the understanding of dependent variables, various factors, and their interaction effects by a desired set of experiments on the responses to be analyzed. The present study describes the risk based HPLC method development and validation of ceftriaxone sodium in pharmaceutical dosage form. Results An efficient experimental design based on central composite design of two key components of the RP-HPLC method (mobile phase and pH) is presented. The chromatographic conditions were optimized with the Design Expert software 11.0 version, i.e., Phenomenex ODS column C18 (250 mm × 4.6 mm, 5.0 μ), mobile phase used acetonitrile to water (0.01% triethylamine with pH 6.5) (70:30, v/v), and the flow rate was 1 ml/min with retention time 4.15 min. The developed method was found to be linear with r2 = 0.991 for range of 10–200 μg/ml at 270 nm detection wavelength. The system suitability test parameters, tailing factor and theoretical plates, were found to be 1.49 and 5236. The % RSD for intraday and inter day precision was found to be 0.70–0.94 and 0.55–0.95 respectively. The robustness values were less than 2%. The assay was found to be 99.73 ± 0.61%. The results of chromatographic peak purity indicate the absence of any coeluting peaks with the ceftriaxone sodium peak. The method validation parameters were in the prescribed limit as per ICH guidelines. Conclusion The central composite design experimental design describes the interrelationships of mobile phase and pH at three different level and responses to be observed were retention time, theoretical plates, and peak asymmetry with the help of the Design Expert 11.0 version. Here, a better understanding of the factors that influence chromatographic separation with greater confidence in the ability of the developed HPLC method to meet their intended purposes is done. The QbD approach to analytical method development was used for better understanding of method variables with different levels.
Title: QbD approach to HPLC method development and validation of ceftriaxone sodium
Description:
Abstract Background Quality by design (QbD) refers to the achievement of certain predictable quality with desired and predetermined specifications.
A quality-by-design approach to method development can potentially lead to a more robust/rugged method due to emphasis on risk assessment and management than traditional or conventional approach.
An important component of the QbD is the understanding of dependent variables, various factors, and their interaction effects by a desired set of experiments on the responses to be analyzed.
The present study describes the risk based HPLC method development and validation of ceftriaxone sodium in pharmaceutical dosage form.
Results An efficient experimental design based on central composite design of two key components of the RP-HPLC method (mobile phase and pH) is presented.
The chromatographic conditions were optimized with the Design Expert software 11.
0 version, i.
e.
, Phenomenex ODS column C18 (250 mm × 4.
6 mm, 5.
0 μ), mobile phase used acetonitrile to water (0.
01% triethylamine with pH 6.
5) (70:30, v/v), and the flow rate was 1 ml/min with retention time 4.
15 min.
The developed method was found to be linear with r2 = 0.
991 for range of 10–200 μg/ml at 270 nm detection wavelength.
The system suitability test parameters, tailing factor and theoretical plates, were found to be 1.
49 and 5236.
The % RSD for intraday and inter day precision was found to be 0.
70–0.
94 and 0.
55–0.
95 respectively.
The robustness values were less than 2%.
The assay was found to be 99.
73 ± 0.
61%.
The results of chromatographic peak purity indicate the absence of any coeluting peaks with the ceftriaxone sodium peak.
The method validation parameters were in the prescribed limit as per ICH guidelines.
Conclusion The central composite design experimental design describes the interrelationships of mobile phase and pH at three different level and responses to be observed were retention time, theoretical plates, and peak asymmetry with the help of the Design Expert 11.
0 version.
Here, a better understanding of the factors that influence chromatographic separation with greater confidence in the ability of the developed HPLC method to meet their intended purposes is done.
The QbD approach to analytical method development was used for better understanding of method variables with different levels.

Related Results

Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Abstract Introduction Among the most frequently used anticoagulants in hematological testing are tetra-acetic acid (EDTA), sodium citrate, and sodium heparin. However, there is a n...
Quality by Design (QbD) in pharmaceutical development: A comprehensive review
Quality by Design (QbD) in pharmaceutical development: A comprehensive review
Quality by Design (QBD) represents a transformative approach to pharmaceutical development, emphasizing a systematic and science-driven methodology to ensure consistent product qua...
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Abstract Background: Access to ceftriaxone is still low, causing 11% of patients not to complete their treatment at health facilities in Uganda; which could increase antimi...
Synergistic effect of Ceftriaxone and diclofenac against Escherichia Coli
Synergistic effect of Ceftriaxone and diclofenac against Escherichia Coli
Background: The emergence of resistant strains of bacteria has rendered many useful antibiotics ineffective. The researchers areforced to try combination of two or more antibiotics...
Evaluation of Ceftriaxone utilization among selected hospitals in Dar-es-Salaam, Tanzania
Evaluation of Ceftriaxone utilization among selected hospitals in Dar-es-Salaam, Tanzania
Objectives: Inappropriate use of ceftriaxone has been reported to increase treatment cost among patients. In addition, inappropriate use is a threat for resistance development. We ...
Validation in Doctoral Education: Exploring PhD Students’ Perceptions of Belonging to Scaffold Doctoral Identity Work
Validation in Doctoral Education: Exploring PhD Students’ Perceptions of Belonging to Scaffold Doctoral Identity Work
Aim/Purpose: The aim of this article is to make a case of the role of validation in doctoral education. The purpose is to detail findings from three studies which explore PhD stude...
Prevalence and Characteristics of Ceftriaxone-Resistant Salmonella in Children’s Hospital in Hangzhou, China
Prevalence and Characteristics of Ceftriaxone-Resistant Salmonella in Children’s Hospital in Hangzhou, China
The non-Typhi Salmonella (NTS) infection is critical to children’s health, and the ceftriaxone is the important empirical treatment choice. With the increase resistance rate of cef...

Back to Top